Skip to main content

Day: August 24, 2020

Pranešimas dėl banko finansinės ataskaitos už 2020 metų šešių mėnesių laikotarpį

Vilnius, Aug. 24, 2020 (GLOBE NEWSWIRE) —Medicinos bankas pirmąjį pusmetį uždirbo tiek pat pelno kaip pernaiMedicinos bankas šių metų sausio-birželio mėnesiais uždirbo 1,55 mln. eurų grynojo pelno. Tai vos 0,6 proc. mažiau nei tuo pačiu 2019 m. periodu (1,56 mln. eurų).„Nepaisant COVID-19 poveikio tiesioginės veiklos pajamoms, pavyko pasiekti geresnių rezultatų nei planuota pirmojo ketvirčio pabaigoje, paskelbus karantiną. Apribojus fizinį klientų aptarnavimą, susitelkėme į vidinių procesų optimizavimą, nuotolinio aptarnavimo proceso efektyvinimą, elektroninių paslaugų plėtrą. Ir toliau didžiausią dėmesį skirsime paslaugų skaitmenizavimui, elektroninių finansavimo sprendimų automatizavimui – išliekant situacijos neapibrėžtumui, turime būti maksimaliai pasiruošę bet kokiems galimiems išorinės aplinkos pokyčiams“, – sako Dalia Klišauskienė,...

Continue reading

Information on Financial statements for the six month period

Vilnius, Aug. 24, 2020 (GLOBE NEWSWIRE) — Over the first six months, Medicinos Bankas generated as much profit as last year     From January to June of this year, Medicinos Bankas generated net profit of EUR 1.55 million. This is only 0.6 per cent less than the profit generated over the same period of 2019 (EUR 1.56 million).  “Despite the impact of COVID-19 on the income from primary activities, we have managed to achieve the results better than those planned for the end of the first quarter, once the quarantine was introduced. After placing restrictions on the physical customer service, we focused on the optimisation of internal processes, improving the remote service process, development of electronic services. We will continue to focus mostly on the digitization of services and automation of the electronic financing solutions....

Continue reading

Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for COVID-19 and other pulmonary diseases

NEW YORK and LONDON, Aug. 24, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office (“USPTO”) has granted a patent for methods and use of fully human monoclonal antibody (mAb; TZLS-501) that recognizes both IL-6 receptor (IL-6R) and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases. The Company initially entered into a world-wide exclusive license from Novimmune, SA., a Swiss Biotechnology company in 2017. The license is currently maintained with Bristol Myers Squibb. The patent (No. 10,759,862) will be published by the USPTO on September 1, 2020. The...

Continue reading

Auriant Mining Q2 2020 Interim Report and Online Conference, August 31st 2020

Auriant Mining AB is pleased to announce that the Company’s Q2 2020 interim report will be published on Monday, August 31st.This will be followed by an interactive webcast for analysts and investors with the CEO, Sergey Ustimenko, who will be presenting Auriant Mining’s Q2 2020 results as well as hosting a Q&A session.The event will begin at 13:00 CET (13:00 Stockholm, 14:00 Moscow, 12:00 London).Those who wish to receive an email reminder an hour before the event can pre-register using the link or open the link directly to participate in Online Conference on Monday, August 31st:Link to register on Q2 2020 Interim Report Online ConferenceFor more information, please contact:Sergey Ustimenko, CEOTel: +7 495 109 02 82E-mail: sergey.ustimenko@auriant.comCompany name: Auriant Mining ABShort name: AURISIN-code: SE0001337213Website: www.auriant.comwww.facebook.com/AuriantMining/Auriant...

Continue reading

Auriant Mining:s delårsrapport för Q2 2020 och online-konferens den 31 augusti 2020

Auriant Mining AB har nöjet att meddela att Bolagets delårsrapport för Q2 2020 kommer att publiceras på måndagen den 31 augusti.Detta kommer att följas av en interaktiv webcast för analytiker och investerare med vd Sergey Ustimenko som kommer att presentera Auriant Mining:s resultat för Q2 2020 samt med en möjlighet att ställa frågor.Evenemanget börjar kl. 13:00 CET (13:00 Stockholm, 14:00 Moskva, 12:00 London).De som vill få en e-postpåminnelse en timme innan evenemanget kan registrera sig genom länken eller öppna följande länk direkt för att delta i online-konferensen måndagen den 31 augusti:Link to register on Q2 2020 Interim Report Online ConferenceFör mer information, vänligen kontakta:Sergey Ustimenko, VDTel: +7 495 109 02 82E-post: sergey.ustimenko@auriant.comFöretagsnamn: Auriant Mining ABKortnamn: AURISIN-kod: SE0001337213Website:...

Continue reading

BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV

Acacia Pharma’s BARHEMSYS® (amisulpride injection) Launched and Commercially Available in the US for the Treatment and Prevention of Postoperative Nausea & Vomiting (PONV)This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.Cambridge, UK and Indianapolis, US – 24 August 2020: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy, announces today that BARHEMSYS® (amisulpride injection) has been launched and is now commercially available in the US for order and delivery to customers through major wholesalers and specialty...

Continue reading

INVESTORS HOUSE H1 2020 – YHTIÖ VALMISTAUTUU SEURAAVAAN STRATEGIAKAUTEEN

Investors House Oyj                                                    Puolivuosikatsaus H1 2020                                                                INVESTORS HOUSE H1 2020 – YHTIÖ VALMISTAUTUU SEURAAVAAN STRATEGIAKAUTEENInvestors House toimii kiinteistöliiketoiminnan koko arvoketjussa. Arvoketju ulottuu tonttihankinnasta hankekehityksen, vuokrauksen ja omistamisen kautta kiinteistövarainhoitoon ja rahastoihin. Yhtiö tavoittelee sellaista kasvua ja kannattavuutta, että osakkeenomistajan vuotuinen osingosta ja arvonkehityksestä muodostuva kokonaistuotto olisi vähintään 10 % vuodessa pitkällä aikavälillä.YHTEENVETO KAUDELTA 4-6/2020 (VERTAILUKAUSI 4-6/2019)Katsauskaudella johdon huomion keskipisteessä oli tulevan strategiakauden kannalta tärkeiden liiketoiminnan kehityshankkeiden eteenpäinvieminen sekä välittömät toimet korona-viruksen...

Continue reading

VGP NV: Reports Results for First Half 2020

24 August 2020, 7:00am, Antwerp (Berchem), Belgium: VGP NV (‘VGP’ or ‘the Group’), the Antwerp-based European provider of high-quality logistics and semi-industrial real estate, today announces the results for half-year ended 30 June 2020: Operating performance resulting in a net profit of € 196.9 millionResult positively affected by the entering into a new 50:50 joint venture with Allianz Real Estate in respect of VGP Park München€ 20.1 million worth of signed and renewed lease agreements during H1 2020, bringing total annualised rental income to € 165.2 million (+6.6% YTD)1 Delivered 12 projects for a total of 190,000 m2 of lettable area in first half of 202033 projects under construction for a total of 795,000 m2 of lettable area as of 30 June 2020Total portfolio value increased to €3.23 billion (+16.6%YTD)1VGP invested in its future...

Continue reading

VGP NV: Rapporteert Resultaten Over Eerste Helft 2020

24 augustus 2020, 7.00 uur CET, Antwerpen (Berchem), België: VGP NV (‘VGP’ of ‘de Groep’), de in Antwerpen gevestigde Europese aanbieder van hoogwaardig logistiek en semi-industrieel vastgoed maakt vandaag de resultaten bekend voor het halfjaar eindigend op 30 juni 2020: Operationele prestaties die resulteren in een nettowinst van € 196,9 miljoenResultaat positief beïnvloed door het aangaan van een nieuwe 50:50 joint venture met Allianz Real Estate met betrekking tot VGP Park München€ 20,1 miljoen aan nieuwe en hernieuwde huurovereenkomsten in H1 2020, waardoor totaal geannualiseerde huurinkomsten groeien tot € 165,2 miljoen (+6,6% YTD)1 12 projecten opgeleverd voor een totaal van 190.000 m2 verhuurbare oppervlakte33 projecten in aanbouw voor een totaal van 795.000 m2 verhuurbare oppervlakteDe totale waarde van...

Continue reading

Maha Energy AB Announces Filing of Second Quarter Report & Live Webcast

                                                                Press releaseStockholm24 August 2020                                                                                                                                                                                            Maha Energy AB Announces Filing of Second Quarter Report & Live WebcastMaha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce its Second Quarter results.  The report is attached to this press release and available on the Company’s website at www.mahaenergy.ca.Second Quarter 2020Record daily oil & gas production for Q2 2020 averaged 3,602 BOEPD (Q2 2019: 2,739 BOEPD)Illinois Basin, acquired at the end of Q1 2020, averaged at 144 BOEPD for Q2 2020Revenue of USD 7.9 million (Q2 2019: USD 14.1 million)Operating netback of USD 4.4...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.